Two New Lenses for Cataract Patients Launched in the United States

Abbott has announced the US launch of its Technis Multifocal +2.75D and +3.25D intraocular lenses (IOLs), products that the manufacturer claims will improve the vision of patients with cataracts at multiple distances.

The 2 new IOLs will join Abbott’s TECNIS Multifocal +4.0D on the US market, giving cataract patients a wider variety of vision improvement choices. While each of Abbott’s Multifocal IOLs are each tailored to meet specific patient needs, all 3 provide excellent vision at near, intermediate, and far distances, according to a company press release.

“Restoring or improving sight can make a huge impact on how people live their lives, which is why Abbott is continually investing in the research and development of advanced treatments to help people see their very best,” said Murthy Simhambhatla, senior vice president of medical optics for Abbott, in a press release. “We are pleased to offer the new TECNIS Multifocal IOLs for people with cataracts who want a full range of vision without having to wear eyeglasses, and who also want high-quality vision at a specific distance that is suited to their lifestyle.”

The Technis Multifocal +2.75D and +3.25D IOLs were previously approved by the FDA based on the results of a study that enrolled 445 cataract patients. More than 80% of trial participants who were given the IOLs were able to function comfortably without glasses at all distances.

“My patients are extremely satisfied with the new TECNIS Multifocal lenses,” said Kerry Assil, MD, medical director of the Assil Eye Institute in Los Angeles, in the press release. “Many of them are able to read easily, not only up close, but at intermediate distance as well, and in all lighting conditions. This improved vision following cataract surgery helps people live the active lives they want.”